We are live on ! Find out more
DC

Davenport & Co Portfolio holdings

AUM $20.4B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+20.34%
1 Year Est. Return
+18.11%
3 Year Est. Return
+63.26%
5 Year Est. Return
+74.4%
10 Year Est. Return
+287.26%
AUM
$8.21B
AUM Growth
+$1.26B
Cap. Flow
+$43.3M
Cap. Flow %
0.53%
Top 10 Hldgs %
22.41%
Holding
741
New
78
Increased
241
Reduced
314
Closed
39

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$58.4M
2
AON icon
Aon
AON
+$47.4M
3
MDT icon
Medtronic
MDT
+$43M
4
SBUX icon
Starbucks
SBUX
+$38.6M
5
LMT icon
Lockheed Martin
LMT
+$38.5M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$47.7M
2
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$41.1M
3
XOM icon
ExxonMobil
XOM
+$34.1M
4
DAL icon
Delta Air Lines
DAL
+$32.8M
5
KMX icon
CarMax
KMX
+$28.5M

Sector Composition

Rank Sector Weight
1 Financials 18.82%
2 Technology 12.84%
3 Healthcare 11.54%
4 Consumer Discretionary 10.44%
5 Communication Services 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGVT icon
276
Ingevity
NGVT
$2.54B
$1.42M 0.02%
27,089
– –
MAR icon
277
Marriott International
MAR
$98.3B
$1.4M 0.02%
16,272
-3,176
-16% -$276K
MLCO icon
278
Melco Resorts & Entertainment
MLCO
$2.22B
$1.38M 0.02%
88,625
+15,275
+21% +$236K
USFR
279
DELISTED
WisdomTree Bloomberg Floating Rate Treasury Fund
USFR
$1.37M 0.02%
54,600
– –
SYK icon
280
Stryker
SYK
$125B
$1.36M 0.02%
7,574
+3,197
+73% +$590K
VGT icon
281
Vanguard Information Technology ETF
VGT
$139B
$1.36M 0.02%
39,016
+464
+1% +$14.5K
SGMO
282
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.35M 0.02%
151,045
-29,745
-16% -$276K
TROW icon
283
T. Rowe Price
TROW
$23.9B
$1.35M 0.02%
10,904
-151
-1% -$17.2K
RY icon
284
Royal Bank of Canada
RY
$291B
$1.34M 0.02%
19,840
+320
+2% +$20.4K
BLPH
285
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1.34M 0.02%
+107,150
New +$1.5M
SONY icon
286
Sony
SONY
$137B
$1.33M 0.02%
96,395
-900
-0.9% -$11.7K
OMC icon
287
Omnicom Group
OMC
$21.6B
$1.32M 0.02%
24,194
-111
-0.5% -$6.04K
ARKG icon
288
ARK Genomic Revolution ETF
ARKG
$1.57B
$1.32M 0.02%
25,298
+1,558
+7% +$66.8K
DIA icon
289
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.8B
$1.32M 0.02%
5,110
-2,514
-33% -$618K
ACV
290
Virtus Diversified Income & Convertible Fund
ACV
$278M
$1.3M 0.02%
56,251
+2,800
+5% +$59.7K
SEIC icon
291
SEI Investments
SEIC
$12.4B
$1.28M 0.02%
23,287
-100
-0.4% -$5.23K
SJM icon
292
J.M. Smucker
SJM
$12.7B
$1.27M 0.02%
12,052
-489
-4% -$54.9K
GSK icon
293
GSK
GSK
$104B
$1.27M 0.02%
24,915
-711
-3% -$36.5K
DLTR icon
294
Dollar Tree
DLTR
$24.4B
$1.27M 0.02%
13,667
-2,850
-17% -$238K
ARKF icon
295
ARK Blockchain & Fintech Innovation ETF
ARKF
$722M
$1.26M 0.02%
+39,995
New +$1.05M
TGT icon
296
Target
TGT
$65.6B
$1.26M 0.02%
10,499
+1,441
+16% +$164K
AMP icon
297
Ameriprise Financial
AMP
$48.3B
$1.25M 0.02%
8,305
-29
-0.3% -$3.72K
AMRN
298
Amarin Corp
AMRN
$299M
$1.24M 0.02%
8,957
-30
-0.3% -$4.13K
IYF icon
299
iShares US Financials ETF
IYF
$4.67B
$1.24M 0.02%
22,474
-2,838
-11% -$151K
ADI icon
300
Analog Devices
ADI
$179B
$1.23M 0.02%
10,061
+268
+3% +$29.4K
10 11
12
13 14

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Davenport & Co's Q2 2020 Portfolio in Review

As of Q2 2020, Davenport & Co held 741 positions worth $8.21B, up 18% from $6.95B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Davenport & Co's Q2 2020 filing shows 78 new, 241 increased, 314 reduced and 39 closed positions. Its largest new stake was Foley Trasimene Acquisition Corp.: 1,574,977 shares worth $16.8M. The largest sale was Merck, an estimated $47.7M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.

  • Davenport & Co's largest Q2 2020 buy was Foley Trasimene Acquisition Corp.: 1,574,977 shares worth $16.8M.
  • Davenport & Co added most to Qualcomm in Q2 2020, an estimated $58.4M increase.
  • Davenport & Co's biggest Q2 2020 reduction was Merck, cutting an estimated $47.7M.
  • Davenport & Co fully exited Trupanion in Q2 2020, selling an estimated $5.3M.
  • Davenport & Co's ten largest holdings make up 22% of its $8.21B portfolio in Q2 2020.
  • Davenport & Co opened 78 new positions and closed 39 in Q2 2020.
  • Davenport & Co's portfolio value rose 18% quarter-over-quarter to $8.21B.

Based on Davenport & Co's 13F filing for Q2 2020, filed 28 Jul 2020.